Sold as Chloromycetin. Every FDA application for this active ingredient: 1 branded and 4 generic.
As of Nov 16, 2026, FDA lists 5 applications for Chloramphenicol Sodium Succinate (sold as Chloromycetin), first approved Feb 20, 1959, with 0 new uses approved and 0 published complete response letters.
| Feb 20, 1959 | ChloromycetinNDA 50155 | Parkedale | 30 | Discontinued |
| Aug 25, 1982 | Chloramphenicol Sodium SuccinateANDA 62365 | Fresenius Kabi USA | 9 | Discontinued |
| — | Mychel-SANDA 60132 | Angus | 0 | Discontinued |
| — | Chloramphenicol Sodium SuccinateANDA 62278 | Gruppo Lepetit | 0 | Discontinued |
| — | ChloramphenicolANDA 62406 | Elkins Sinn | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA